8-K filing — CapsoVision, Inc (CV)
Filed: 2026-09-28 AccNo: 0001378325-26-000045 Size: 173 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
CapsoVision Q2 EPS $(0.15) Misses $(0.13) Estimate, Sales $3.643M Miss $3.813M Estimate
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System
CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M
CapsoVision, Inc.3,163,444 Shares of Common Stock We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors (collectively, the
CapsoVision Q2 2026 Earnings Call Transcript
CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and